Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Identifying locally actionable strategies to increase participant acceptability and feasibility to participate in Phase I cancer clinical trials.
Staras SAS, Wollney EN, Emerson LE, Silver N, Dziegielewski PT, Hansen MD, Sanchez G, D'Ingeo D, Johnson-Mallard V, Renne R, Fredenburg K, Gutter M, Zamojski K, Vandeweerd C, Bylund CL. Staras SAS, et al. Health Expect. 2023 Dec 2;27(1):e13920. doi: 10.1111/hex.13920. Online ahead of print. Health Expect. 2023. PMID: 38041447 Free PMC article.
Investigating miR-9 as a mediator in laryngeal cancer health disparities.
Gobin C, Inkabi S, Lattimore CC, Gu T, Menefee JN, Rodriguez M, Kates H, Fields C, Bian T, Silver N, Xing C, Yates C, Renne R, Xie M, Fredenburg KM. Gobin C, et al. Front Oncol. 2023 Apr 4;13:1096882. doi: 10.3389/fonc.2023.1096882. eCollection 2023. Front Oncol. 2023. PMID: 37081981 Free PMC article.
mRNA aggregates harness danger response for potent cancer immunotherapy.
Mendez-Gomez HR, DeVries A, Castillo P, Stover BD, Qdaisat S, Von Roemeling C, Ogando-Rivas E, Weidert F, McGuiness J, Zhang D, Chung MC, Li D, Zhang C, Marconi C, Campaneria Y, Chardon-Robles J, Grippin A, Karachi A, Thomas N, Huang J, Milner R, Sahay B, Sawyer WG, Ligon JA, Silver N, Simon E, Cleaver B, Wynne K, Hodik M, Molinaro A, Guan J, Kellish P, Doty A, Lee JH, Carrera-Justiz S, Rahman M, Gatica S, Mueller S, Prados M, Ghiaseddin A, Mitchell DA, Sayour EJ. Mendez-Gomez HR, et al. medRxiv [Preprint]. 2023 Mar 17:2023.03.12.23287108. doi: 10.1101/2023.03.12.23287108. medRxiv. 2023. PMID: 36993772 Free PMC article. Updated. Preprint.
mRNA challenge predicts brain cancer immunogenicity and response to checkpoint inhibitors.
Castillo P, Ogando-Rivas E, Geffrard H, Pepe A, Liu R, Nguyen DT, Pedro DI, Zhang D, DeVries A, Qdaisat S, Karachi A, Rahman M, Weidert F, Milner R, Huang J, Silver NL, Ligon J, Li D, Lee JH, Carrera-Justiz S, Mitchell DA, Mendez-Gomez H, Sawyer WG, Sayour EJ. Castillo P, et al. bioRxiv [Preprint]. 2023 Mar 23:2023.03.18.532056. doi: 10.1101/2023.03.18.532056. bioRxiv. 2023. PMID: 36993158 Free PMC article. Preprint.
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).
Michikawa C, Gopalakrishnan V, Harrandah AM, Karpinets TV, Garg RR, Chu RA, Park YP, Chukkapallia SS, Yadlapalli N, Erikson-Carter KC, Gleber-Netto FO, Sayour E, Progulske-Fox A, Chan EKL, Wu X, Zhang J, Jobin C, Wargo JA, Pickering CR, Myers JN, Silver N. Michikawa C, et al. Neoplasia. 2022 Sep;31:100813. doi: 10.1016/j.neo.2022.100813. Epub 2022 Jul 11. Neoplasia. 2022. PMID: 35834946 Free PMC article.